Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224624 · ClinicalTrials.gov registry record · NA
Self-management of Blood Pressure Medication for Hypertensive Veterans
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
NCT03224624: Completed NA study, sponsored by VA Office of Research and Development.
NCT03224624 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 232 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03224624, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
Study Summary
Hypertension is the most common medical problem among US Veterans. Treatment is available and effective, but control rates remain under 75%. While blood pressure control has traditionally been achieved through sequential visits and medication changes initiated by providers during office-based care, self-monitoring and self-management of blood pressure medication is an important strategy that would empower Veterans to achieve better control of blood pressure. The health impacts of better systems for treatment of hypertension are significant, including decreased rates of cardiovascular and kidney disease. This two-site clinical trial will randomize 400 Veterans to either usual blood pressure care or a self-management strategy in which patient-driven self-management of blood pressure medications will be taught and used over the course of 1 year.
Interventions
- OTHER self-management protocol for hypertension care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03224624
The ClinicalTrials.gov registry entry for NCT03224624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which self-management protocol for hypertension care is the first listed.
NCT03224624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03224624 about?
NCT03224624 is a clinical study titled "Self-management of Blood Pressure Medication for Hypertensive Veterans". Hypertension is the most common medical problem among US Veterans. Treatment is available and effective, but control rates remain under 75%. While blood pressure control has traditionally been achieved through sequential visits and medication changes initiated by providers during office-based care, ...
What is the current status of trial NCT03224624?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2018-02-21. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT03224624?
The interventions under investigation include: self-management protocol for hypertension care (OTHER).
Who is sponsoring clinical trial NCT03224624?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.